CANAGLIFLOZIN — all Canadian products
22 DINs
15 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CANAGLIFLOZIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02544520 | AG-CANAGLIFLOZIN | ANGITA PHARMA INC. | Tablet | Oral | CANAGLIFLOZIN 300 MG | Approved | |
| 02544512 | AG-CANAGLIFLOZIN | ANGITA PHARMA INC. | Tablet | Oral | CANAGLIFLOZIN 100 MG | Approved | |
| 02564556 | APO-CANAGLIFLOZIN | APOTEX INC | Tablet | Oral | CANAGLIFLOZIN 100 MG | Marketed | |
| 02564564 | APO-CANAGLIFLOZIN | APOTEX INC | Tablet | Oral | CANAGLIFLOZIN 300 MG | Marketed | |
| 02510375 | AURO-CANAGLIFLOZIN | AURO PHARMA INC | Tablet | Oral | CANAGLIFLOZIN 300 MG | Marketed | |
| 02510367 | AURO-CANAGLIFLOZIN | AURO PHARMA INC | Tablet | Oral | CANAGLIFLOZIN 100 MG | Marketed | |
| 02455420 | INVOKAMET | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02455455 | INVOKAMET | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 150 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02455404 | INVOKAMET | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02425483 | INVOKANA | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 100 MG | Marketed | |
| 02425491 | INVOKANA | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 300 MG | Marketed | |
| 02543494 | JAMP CANAGLIFLOZIN | JAMP PHARMA CORPORATION | Tablet | Oral | CANAGLIFLOZIN 300 MG | Marketed | |
| 02543486 | JAMP CANAGLIFLOZIN | JAMP PHARMA CORPORATION | Tablet | Oral | CANAGLIFLOZIN 100 MG | Marketed | |
| 02510448 | SANDOZ CANAGLIFLOZIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | CANAGLIFLOZIN 300 MG | Approved | |
| 02510421 | SANDOZ CANAGLIFLOZIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | CANAGLIFLOZIN 100 MG | Approved | |
| 02455412 | INVOKAMET | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market | |
| 02455447 | INVOKAMET | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 150 MG; METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market | |
| 02455439 | INVOKAMET | JANSSEN INC | Tablet | Oral | CANAGLIFLOZIN 150 MG; METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market | |
| 02477394 | INVOKAMET XR | JANSSEN INC | Tablet (Extended-Release) | Oral | CANAGLIFLOZIN 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market | |
| 02477424 | INVOKAMET XR | JANSSEN INC | Tablet (Extended-Release) | Oral | CANAGLIFLOZIN 150 MG; METFORMIN HYDROCHLORIDE 1000 MG | Cancelled Pre Market | |
| 02477408 | INVOKAMET XR | JANSSEN INC | Tablet (Extended-Release) | Oral | CANAGLIFLOZIN 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Cancelled Pre Market | |
| 02477416 | INVOKAMET XR | JANSSEN INC | Tablet (Extended-Release) | Oral | CANAGLIFLOZIN 150 MG; METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market |
Browse other molecules: